Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.4412212029398781e-12,6.301074858972404,171.8021475159741,"['RPL3', 'RPL10', 'RPL34', 'RPLP1', 'RPL10A', 'RPL9', 'RPL7', 'RPS14', 'RPS18', 'RPL36', 'RPL35', 'RPL13', 'RPL38', 'RPL37', 'RPL15', 'RPL39', 'RPL17', 'RPS13', 'RPS12', 'RPS9', 'RPL41', 'RPL21', 'RPL23', 'RPS5', 'RPL13A', 'RPS3A', 'RPS26', 'RPL27A', 'RPS21', 'RPS23']",6.874625138023218e-10,0,0,30
2,Calcium Regulation in the Cardiac Cell WP536,2.8585252553891176e-05,3.046686822877299,31.87632532323637,"['RGS17', 'YWHAB', 'KCNB1', 'ITPR1', 'CACNA1A', 'ATP2B1', 'ATP1B1', 'YWHAZ', 'GNAI1', 'RGS4', 'FKBP1A', 'PLN', 'GNG2', 'GRK5', 'PRKAR1A', 'PRKAR2B', 'CAMK4', 'GJA9', 'PRKCQ', 'CALM3', 'YWHAG', 'YWHAH']",0.006817582734103046,0,0,22
3,Differentiation Pathway WP2848,0.00030418685774370963,7.335416666666666,59.40123869200412,"['NT5E', 'NOTCH1', 'CSF1', 'EGF', 'HGF', 'WNT7B', 'VEGFA']",0.04836571038124983,0,0,7
4,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.00048750276054050965,2.7096191479753124,20.664137119993033,"['SNAP25', 'GABRA1', 'CEBPB', 'TSPYL1', 'CHRNA4', 'YWHAB', 'ATP1A3', 'YWHAZ', 'VEGFA', 'PRKAR1A', 'PRKAR2B', 'PAH', 'PLP1', 'HES1', 'SLC25A4', 'YWHAG', 'HES5', 'YWHAH']",0.05024970591548449,0,0,18
5,GABA receptor Signaling WP4159,0.0005267264771015146,5.427221983683984,40.96917158419624,"['GABRA2', 'GABRB2', 'GABRA1', 'GAD1', 'GABRA4', 'SLC6A1', 'GABRD', 'GABRG2']",0.05024970591548449,0,0,8
6,Differentiation of white and brown adipocyte WP2895,0.0016206111259341439,8.21948321948322,52.809784842932736,"['SMAD1', 'CEBPB', 'SMAD9', 'SLC7A10', 'BMP7']",0.12883858451176444,0,0,5
7,Endochondral Ossification with Skeletal Dysplasias WP4808,0.0025927367341178164,3.5790079907854007,21.31314042334308,"['COL10A1', 'SLC38A2', 'BMP7', 'FGFR3', 'GLI3', 'RUNX2', 'IGF1R', 'DDR2', 'VEGFA']",0.1545919277717748,0,0,9
8,Endochondral Ossification WP474,0.0025927367341178164,3.5790079907854007,21.31314042334308,"['COL10A1', 'SLC38A2', 'BMP7', 'FGFR3', 'GLI3', 'RUNX2', 'IGF1R', 'DDR2', 'VEGFA']",0.1545919277717748,0,0,9
9,Proximal tubule transport WP4917,0.0035629343883881864,4.24375,23.922743613216326,"['ABCC4', 'ATP6V0B', 'SLC1A1', 'ATP1A1', 'ATP6V1E1', 'ATP1B1', 'ATP6V0C']",0.17876011933191022,0,0,7
10,NOTCH1 regulation of endothelial cell calcification WP3413,0.0037475916002496896,9.19792315680166,51.38550276516937,"['NOTCH1', 'SAT1', 'FGFR3', 'VEGFA']",0.17876011933191022,0,0,4
11,Myometrial relaxation and contraction pathways WP289,0.004466407999468544,2.20929627439385,11.954879428758618,"['RGS17', 'YWHAB', 'ITPR1', 'YWHAZ', 'ETS2', 'ACTB', 'RGS4', 'ACTA2', 'GNG2', 'GRK5', 'PRKAR1A', 'PRKAR2B', 'PLCG2', 'PRKCQ', 'CALM3', 'YWHAG', 'YWHAH']",0.18032301920381363,0,0,17
12,Role of Osx and miRNAs in tooth development WP3971,0.004560904107431511,17.232883817427386,92.88928326617759,"['NOTCH1', 'BMP7', 'RUNX2']",0.18032301920381363,0,0,3
13,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.005057542409773386,2.7592550482081135,14.587835438775011,"['PSMD10', 'TUBA1C', 'HSPA8', 'TUBA1B', 'TUBB3', 'RNF19A', 'TUBB', 'TUBB4A', 'HSPA1B', 'SNCA', 'HSPA1A']",0.18032301920381363,0,0,11
14,Exercise-induced Circadian Regulation WP410,0.005310552082766833,3.144050104384134,16.468721450914124,"['DNAJA1', 'HSPA8', 'CEBPB', 'SUMO1', 'RBPMS', 'PPP1R3C', 'TUBB3', 'TAB2', 'ERC2']",0.18032301920381363,0,0,9
15,FOXA2 pathway WP5066,0.0058520622302753456,7.664243682935272,39.401579109019906,"['ABCC4', 'IRS1', 'FASN', 'IRS2']",0.18032301920381363,0,0,4
16,Synaptic Vesicle Pathway WP2267,0.006248986393768431,3.0513017315485693,15.486381541415914,"['NSF', 'SNAP25', 'STX1B', 'SYT1', 'CACNA1A', 'SYP', 'CPLX2', 'SLC25A4', 'CPLX1']",0.18032301920381363,0,0,9
17,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.00642660655443361,4.316207075962539,21.78522923232817,"['HSP90AA1', 'ACAP1', 'IL18', 'ERBIN', 'NOD1', 'NLRP1']",0.18032301920381363,0,0,6
18,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.008321650030230847,3.5044384057971016,16.782386588147535,"['GABRA2', 'GABRB2', 'GABRA1', 'SLC12A5', 'GABRA4', 'GABRD', 'GABRG2']",0.21331188879461796,0,0,7
19,Complement and Coagulation Cascades WP558,0.009032050774861168,4.792532917532918,22.558336609643053,"['C1R', 'PROS1', 'SERPING1', 'F3', 'KLKB1']",0.21331188879461796,0,0,5
20,Monoamine Transport WP727,0.009032050774861168,4.792532917532918,22.558336609643053,"['IL1R1', 'TNFRSF11B', 'AMPH', 'SLC6A1', 'FBXO32']",0.21331188879461796,0,0,5
21,Apoptosis Modulation and Signaling WP1772,0.009661638562097329,2.4876117811141194,11.541503772835073,"['CAPNS1', 'IL1R1', 'BAG3', 'TRAF6', 'TOLLIP', 'FAS', 'CYCS', 'TNFRSF11B', 'MAP3K14', 'BCL2L2', 'HSPA1A']",0.21331188879461796,0,0,11
22,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.009838284179206697,2.8031371663939515,12.95462540721491,"['CEBPB', 'NOTCH1', 'WNT7B', 'HMGA2', 'TNFRSF11B', 'HES1', 'ACTB', 'RUNX2', 'HES5']",0.21331188879461796,0,0,9
23,Nuclear Receptors Meta-Pathway WP2882,0.011499596014004422,1.7476139978791092,7.803871346172461,"['NQO1', 'ABCC4', 'HSP90AA1', 'SLC6A17', 'SLC10A1', 'HGF', 'SLC39A11', 'AIP', 'IRS2', 'DBI', 'SMARCA1', 'SLC6A1', 'SLC5A3', 'FASN', 'ENC1', 'SPINK13', 'HES1', 'SPRY1', 'GCLM', 'SLC39A1', 'EPHA3', 'SLC19A2', 'CBR3', 'HSPA1A']",0.23849162168174387,0,0,24
24,Vitamin D Receptor Pathway WP2877,0.012215477118759805,2.3933054393305437,10.542633751296671,"['CEACAM1', 'BCL6', 'SATB1', 'CREG2', 'S100A6', 'TIMP2', 'CD9', 'PRKCQ', 'TNFRSF11B', 'ATP2C2', 'ATP2B1']",0.24278260773535112,0,0,11
25,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.014122886177303812,8.614885892116183,36.69905779818659,"['CSF1', 'ID2', 'RUNX2']",0.25910064256053533,0,0,3
26,Gene regulatory network modelling somitogenesis  WP2854,0.014122886177303812,8.614885892116183,36.69905779818659,"['LFNG', 'NOTCH1', 'HES1']",0.25910064256053533,0,0,3
27,Pathogenic Escherichia coli infection WP2272,0.014818123624666925,2.791797010775113,11.758781773413357,"['TUBA1C', 'TUBA1B', 'TUBB3', 'TUBB', 'ARPC5L', 'YWHAZ', 'TUBB4A', 'ACTB']",0.261786850702449,0,0,8
28,NRF2 pathway WP2884,0.015997631498334112,2.112351256385272,8.735236988860487,"['ABCC4', 'NQO1', 'HSP90AA1', 'SLC6A17', 'HGF', 'SLC39A11', 'SLC6A1', 'SLC5A3', 'GCLM', 'SLC39A1', 'EPHA3', 'CBR3', 'HSPA1A']",0.27253107945376326,0,0,13
29,Vitamin D-sensitive calcium signaling in depression WP4698,0.01808413644564529,3.2870521777909913,13.190020555503692,"['GRIN2A', 'GRM5', 'GPX4', 'ITPR1', 'ATP2B4', 'ATP2B1']",0.2814024891413664,0,0,6
30,Benzene metabolism WP3891,0.018288212082562597,22.955440414507773,91.85616211131403,"['NQO1', 'EPHX1']",0.2814024891413664,0,0,2
31,Drug Induction of Bile Acid Pathway WP2289,0.018288212082562597,22.955440414507773,91.85616211131403,"['ABCC4', 'SLC10A1']",0.2814024891413664,0,0,2
32,Glycolysis and Gluconeogenesis WP534,0.02149705409672743,3.13735691987513,12.046946624932188,"['TPI1', 'MDH1', 'MDH2', 'PGAM1', 'PGK1', 'ENO2']",0.3189496726351755,0,0,6
33,Common Pathways Underlying Drug Addiction WP2636,0.022447429500171905,2.7778735632183906,10.54641690764233,"['GRIN2A', 'GRM5', 'CAMK4', 'GNAI1', 'GRM1', 'ACTB', 'GRIA4']",0.3189496726351755,0,0,7
34,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.02273435821718232,3.593100311850312,13.595852937768145,"['HSPB8', 'HSPB1', 'NEFL', 'NDRG1', 'RAB11A']",0.3189496726351755,0,0,5
35,Vitamin A and carotenoid metabolism WP716,0.027530763309463812,3.381435734376911,12.14764297581295,"['RBP2', 'RBP1', 'BCO1', 'RXRG', 'RLBP1']",0.3679944332500372,0,0,5
36,Osteoblast differentiation WP4787,0.027773164773587714,2.07792029631662,7.4466118394904175,"['HES6', 'SMAD1', 'NOTCH1', 'FGF9', 'WNT7B', 'SMAD9', 'PRKCQ', 'PIK3C2A', 'FGFR3', 'RUNX2', 'GLI3']",0.3679944332500372,0,0,11
37,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.030020847677124037,5.742219917012448,20.13143758578814,"['GRM3', 'GRM5', 'GRM1']",0.37548676295421074,0,0,3
38,Nicotine Activity on Dopaminergic Neurons WP1602,0.030020847677124037,5.742219917012448,20.13143758578814,"['GNG2', 'CHRNA4', 'GNAI1']",0.37548676295421074,0,0,3
39,IL-18 signaling pathway WP4754,0.031352330899627134,1.628105623111086,5.637261445170387,"['CEBPB', 'NRN1', 'TICAM2', 'EPB41', 'HSPB8', 'IL18', 'PLOD3', 'HSPB1', 'TNFRSF11B', 'RUNX2', 'PTMS', 'VEGFA', 'ACTA2', 'SOCS3', 'TMSB4X', 'TRAF6', 'STMN1', 'FAS', 'CYCS', 'KIFC3', 'CDK5R2']",0.37548676295421074,0,0,21
40,Aryl Hydrocarbon Receptor Netpath WP2586,0.03426061793950341,2.760124869927159,9.31199542958993,"['NQO1', 'HSP90AA1', 'KLF6', 'AIP', 'HRAS', 'VEGFA']",0.37548676295421074,0,0,6
41,Complement system WP2806,0.03426061793950341,2.760124869927159,9.31199542958993,"['C1R', 'PROS1', 'SERPING1', 'CD59', 'LAMB1', 'KLKB1']",0.37548676295421074,0,0,6
42,Mitochondrial CIV Assembly WP4922,0.03426061793950341,2.760124869927159,9.31199542958993,"['COX8A', 'COX19', 'COA3', 'PNKD', 'COX4I1', 'PET117']",0.37548676295421074,0,0,6
43,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.03445986916024271,3.8300449982692975,12.89943775775064,"['NQO1', 'ABCC4', 'EPHX1', 'GCLM']",0.37548676295421074,0,0,4
44,Blood Clotting Cascade WP272,0.03463609553456032,11.476683937823834,38.59446891968935,"['F3', 'KLKB1']",0.37548676295421074,0,0,2
45,Signal transduction through IL1R WP4496,0.03893006424266098,3.0249480249480247,9.818946402714003,"['IL1R1', 'TRAF6', 'TOLLIP', 'IL1RAP', 'MAP3K14']",0.4098030457652938,0,0,5
46,Eicosanoid Synthesis WP167,0.04037891645905411,4.921458209839953,15.795161748229845,"['PNPLA3', 'ALOX12', 'PLA2G5']",0.4098030457652938,0,0,3
47,IL1 and megakaryocytes in obesity WP2865,0.04037891645905411,4.921458209839953,15.795161748229845,"['IL1R1', 'IL18', 'TIMP2']",0.4098030457652938,0,0,3
48,Globo Sphingolipid Metabolism WP1424,0.0422838240525263,3.5351066379103764,11.182781973377649,"['ST6GAL1', 'ST6GAL2', 'ST8SIA1', 'FUT2']",0.4201955015219801,0,0,4
49,Ferroptosis WP4313,0.045018134487192336,2.55520869464678,7.92290974534197,"['MAP1LC3A', 'GPX4', 'PCBP1', 'ACSL6', 'GCLM', 'SAT1']",0.43823775817123967,0,0,6
50,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.05102363945945991,3.282302329031301,9.766379752557947,"['IFIH1', 'IFNAR2', 'TRAF6', 'IRF7']",0.44539300055732184,0,0,4
51,Urea cycle and associated pathways WP4595,0.05102363945945991,3.282302329031301,9.766379752557947,"['OAT', 'MDH1', 'MDH2', 'GLS2']",0.44539300055732184,0,0,4
52,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.05228932501301892,4.305886929460581,12.706513180649647,"['ITPR1', 'CD38', 'GNAI1']",0.44539300055732184,0,0,3
53,Fatty acid transporters WP5061,0.05228932501301892,4.305886929460581,12.706513180649647,"['FABP3', 'ACSL6', 'DBI']",0.44539300055732184,0,0,3
54,GDNF/RET signaling axis WP4830,0.05228932501301892,4.305886929460581,12.706513180649647,"['IFT27', 'SPRY1', 'GLI3']",0.44539300055732184,0,0,3
55,Hypertrophy Model WP516,0.05228932501301892,4.305886929460581,12.706513180649647,"['IL1R1', 'IL18', 'VEGFA']",0.44539300055732184,0,0,3
56,Leptin Insulin Overlap WP3935,0.05228932501301892,4.305886929460581,12.706513180649647,"['SOCS3', 'IRS1', 'IRS2']",0.44539300055732184,0,0,3
57,PTF1A related regulatory pathway WP4147,0.05468626164676252,7.650431778929188,22.233246919809094,"['NOTCH1', 'HES1']",0.45763766325448635,0,0,2
58,Prolactin Signaling Pathway WP2037,0.058092263781471185,1.9540709812108559,5.5607443000699535,"['SOCS3', 'PAK1', 'IRS1', 'FLNA', 'IRS2', 'HRAS', 'YWHAZ', 'PPIA', 'YWHAG']",0.47775879006485783,0,0,9
59,PKC-gamma calcium signaling pathway in ataxia WP4760,0.060671596757144425,3.0632052613361025,8.583957671576364,"['ITPR1', 'CACNA1A', 'GRM1', 'GRIA4']",0.4905144347992863,0,0,4
60,Cori Cycle WP1946,0.06568027832974221,3.827109266943292,10.421052346195628,"['TPI1', 'PGAM1', 'PGK1']",0.5221582127214506,0,0,3
61,Bladder cancer WP2828,0.06924346815332103,2.4979661936183675,6.6698856324114315,"['EGF', 'DAPK2', 'HRAS', 'FGFR3', 'VEGFA']",0.5297429362877557,0,0,5
62,The influence of laminopathies on Wnt signaling WP4844,0.06924346815332103,2.4979661936183675,6.6698856324114315,"['CEBPB', 'HMGA2', 'HES1', 'HES5', 'RUNX2']",0.5297429362877557,0,0,5
63,Toll-like Receptor Signaling related to MyD88 WP3858,0.07121104054893154,2.871495327102804,7.586799077773922,"['TICAM2', 'TRAF6', 'TOLLIP', 'IRF7']",0.5297429362877557,0,0,4
64,TGF-beta Receptor Signaling WP560,0.07223305399685816,2.224698734517136,5.8461913131536685,"['FKBP1A', 'SMAD1', 'EGF', 'SMAD9', 'HRAS', 'RUNX2']",0.5297429362877557,0,0,6
65,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.0723370451452053,2.0637286324786324,5.420215884926279,"['IL1R1', 'TRAF6', 'TOLLIP', 'IRF7', 'TAB2', 'IL1RAP', 'MAP3K14']",0.5297429362877557,0,0,7
66,Aspirin and miRNAs WP4707,0.07774005354327652,5.737305699481865,14.655285696084675,"['ABCC4', 'VEGFA']",0.5297429362877557,0,0,2
67,Biogenic Amine Synthesis WP550,0.07774005354327652,5.737305699481865,14.655285696084675,"['GAD1', 'PAH']",0.5297429362877557,0,0,2
68,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.07774005354327652,5.737305699481865,14.655285696084675,"['SMAD1', 'SMAD9']",0.5297429362877557,0,0,2
69,Farnesoid X receptor pathway WP2879,0.07774005354327652,5.737305699481865,14.655285696084675,"['SLC10A1', 'IRS2']",0.5297429362877557,0,0,2
70,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.07774005354327652,5.737305699481865,14.655285696084675,"['LFNG', 'NOTCH1']",0.5297429362877557,0,0,2
71,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.08046197280746677,3.444087136929461,8.678998307039494,"['EGF', 'HSPB1', 'ETS2']",0.5330605698494674,0,0,3
72,Phytochemical activity on NRF2 transcriptional activation WP3,0.08046197280746677,3.444087136929461,8.678998307039494,"['NQO1', 'CEBPB', 'GCLM']",0.5330605698494674,0,0,3
73,Heart Development WP1591,0.08261732781526084,2.7023395027793047,6.7383804036768,"['SMAD1', 'NOTCH1', 'NFATC1', 'VEGFA']",0.5398419913408139,0,0,4
74,Splicing factor NOVA regulated synaptic proteins WP4148,0.08871664743181648,2.0894901144641,5.0613880452508155,"['EPB41', 'EPB41L3', 'GRIK2', 'NCDN', 'ATP2B1', 'GABRG2']",0.5718627138510333,0,0,6
75,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.09070393269064443,1.415785764622974,3.398104663866315,"['IFNAR2', 'CRTC2', 'HSP90AA1', 'CSF1', 'CAB39L', 'IRS1', 'EGF', 'HGF', 'LPAR3', 'IRS2', 'LAMB1', 'OSMR', 'PIK3C2A', 'VEGFA', 'IGF1R', 'GNG2', 'FGF9', 'TNR', 'HRAS', 'FGFR3', 'EIF4B']",0.5768770119124986,0,0,21
76,Hematopoietic Stem Cell Differentiation WP2849,0.09485879500073618,2.551978770047306,6.010843674334714,"['HES6', 'NOTCH1', 'CSF1', 'TRIM29']",0.5828547746020114,0,0,4
77,ERK Pathway in Huntington's Disease WP3853,0.09653150355043794,3.1307053941908713,7.319231879953789,"['EGF', 'HRAS', 'GRM1']",0.5828547746020114,0,0,3
78,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.09653150355043794,3.1307053941908713,7.319231879953789,"['TRAF6', 'BCL2L2', 'VEGFA']",0.5828547746020114,0,0,3
79,Transcription factor regulation in adipogenesis WP3599,0.09653150355043794,3.1307053941908713,7.319231879953789,"['CEBPB', 'IRS1', 'IRS2']",0.5828547746020114,0,0,3
80,T-cell receptor (TCR) signaling pathway WP69,0.09796298444652927,1.803512645934286,4.189858504638208,"['PAK1', 'TRAF6', 'ITPR1', 'FAS', 'PRKCQ', 'NFATC1', 'HRAS', 'MAP3K14']",0.5841042947624309,0,0,8
81,Spinal Cord Injury WP2431,0.09947742100383555,1.725,3.980997409389678,"['RTN4R', 'FKBP1A', 'LGALS3', 'VCAN', 'IL1R1', 'APEX1', 'XYLT1', 'PLA2G5', 'GFAP']",0.5858114792448094,0,0,9
82,"GPCRs, Class B Secretin-like WP334",0.1031869460435575,4.589430051813472,10.423572855556722,"['CALCRL', 'ADGRG2']",0.5915771521189266,0,0,2
83,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.1031869460435575,4.589430051813472,10.423572855556722,"['HES1', 'VEGFA']",0.5915771521189266,0,0,2
84,Genotoxicity pathway WP4286,0.10707157953834893,1.9697339081314107,4.400893152240069,"['ARRDC4', 'ACTA2', 'ITPKC', 'DAAM1', 'ID2', 'ITPR1']",0.5915771521189266,0,0,6
85,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.10707157953834893,1.9697339081314107,4.400893152240069,"['FKBP1A', 'SMAD1', 'EGF', 'SMAD9', 'HRAS', 'RUNX2']",0.5915771521189266,0,0,6
86,Aryl Hydrocarbon Receptor Pathway WP2873,0.10789771956886082,2.4174454828660434,5.382615315552049,"['NQO1', 'HSP90AA1', 'AIP', 'HES1']",0.5915771521189266,0,0,4
87,Lung fibrosis WP3624,0.10789771956886082,2.4174454828660434,5.382615315552049,"['CEBPB', 'EGF', 'HGF', 'BMP7']",0.5915771521189266,0,0,4
88,Fas ligand pathway and stress induction of heat shock proteins WP314,0.1209818172658432,2.050972675972676,4.331890184701918,"['PAK1', 'HSPB1', 'FAS', 'CYCS', 'ACTB']",0.655776441315991,0,0,5
89,Hepatitis B infection WP4666,0.12538164105140645,1.480872615563443,3.074873628512186,"['TICAM2', 'ATP6AP1', 'SLC10A1', 'YWHAB', 'NFATC1', 'YWHAZ', 'IFIH1', 'TRAF6', 'IRF7', 'CYCS', 'FAS', 'TAB2', 'HRAS']",0.6719892447361896,0,0,13
90,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.13049492027090762,3.8241796200345424,7.787639602276646,"['FAM20C', 'FGFR3']",0.6765877931437275,0,0,2
91,Peptide GPCRs WP24,0.13049492027090762,3.8241796200345424,7.787639602276646,"['EDNRA', 'NTSR2']",0.6765877931437275,0,0,2
92,RAS and bradykinin pathways in COVID-19 WP4969,0.13049492027090762,3.8241796200345424,7.787639602276646,"['SERPING1', 'KLKB1']",0.6765877931437275,0,0,2
93,Apoptosis Modulation by HSP70 WP384,0.13208093481417799,2.6485796361315033,5.361626764697674,"['FAS', 'CYCS', 'HSPA1A']",0.6774473753372354,0,0,3
94,Interferon type I signaling pathways WP585,0.14905280710102006,1.7670695589530137,3.363536726013129,"['IFNAR2', 'SOCS3', 'IRS1', 'PDCD4', 'IRS2', 'EIF4B']",0.7292946551863192,0,0,6
95,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.14905280710102006,1.7670695589530137,3.363536726013129,"['DDX3Y', 'IFIH1', 'RNF125', 'TRAF6', 'IRF7', 'PIN1']",0.7292946551863192,0,0,6
96,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.15041619768079523,1.5125391849529781,2.8652773585618188,"['COX8A', 'COX7A2L', 'NDUFA5', 'COX4I1', 'NDUFS3', 'ATP5MC3', 'UQCRFS1', 'SLC25A5', 'SLC25A4', 'UQCRH']",0.7292946551863192,0,0,10
97,Angiogenesis WP1539,0.151323181007641,2.459173088322466,4.643748657676238,"['SMAD1', 'TIMP2', 'VEGFA']",0.7292946551863192,0,0,3
98,Aflatoxin B1 metabolism WP699,0.1541373629170493,11.46583850931677,21.440098781254683,['EPHX1'],0.7292946551863192,0,0,1
99,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.1541373629170493,11.46583850931677,21.440098781254683,['FAS'],0.7292946551863192,0,0,1
100,Notch Signaling WP268,0.15863651209513077,1.8519884648916907,3.409769637223008,"['LFNG', 'NUMBL', 'NOTCH1', 'HES1', 'HES5']",0.7292946551863192,0,0,5
101,Development and heterogeneity of the ILC family WP3893,0.15920181318934878,3.2775721687638786,6.02280964084623,"['ID2', 'IL18']",0.7292946551863192,0,0,2
102,Glutathione metabolism WP100,0.15920181318934878,3.2775721687638786,6.02280964084623,"['GPX4', 'GCLM']",0.7292946551863192,0,0,2
103,MAPK Signaling Pathway WP382,0.15946974771971834,1.3173516852219003,2.4185273344980893,"['HSPA8', 'IL1R1', 'EGF', 'CACNA1A', 'HSPB1', 'NFATC1', 'PAK1', 'MRAS', 'FGF9', 'TRAF6', 'STMN1', 'FLNA', 'FAS', 'TAB2', 'HRAS', 'FGFR3', 'MAP3K14', 'HSPA1B', 'HSPA1A']",0.7292946551863192,0,0,19
104,Metapathway biotransformation Phase I and II WP702,0.1629748919140717,1.5209535797617586,2.759251819042014,"['CYP39A1', 'HS3ST3B1', 'CHST6', 'CHST7', 'GPX4', 'EPHX1', 'KCNAB1', 'KCNAB2', 'SULT4A1']",0.7292946551863192,0,0,9
105,IL17 signaling pathway WP2112,0.1671128472878407,1.9962978012551356,3.5715483732093727,"['CEBPB', 'TRAF6', 'MAP3K14', 'IL17RB']",0.7292946551863192,0,0,4
106,Lipid Metabolism Pathway WP3965,0.1671128472878407,1.9962978012551356,3.5715483732093727,"['ACSS2', 'PRKAR2B', 'PRKAR1A', 'FASN']",0.7292946551863192,0,0,4
107,Neural Crest Cell Migration during Development WP4564,0.1671128472878407,1.9962978012551356,3.5715483732093727,"['ARF1', 'PAK1', 'PAK3', 'EPHB1']",0.7292946551863192,0,0,4
108,Ebstein-Barr virus LMP1 signaling WP262,0.1713830958964297,2.2950207468879666,4.048081298169806,"['HSP90AA1', 'TRAF6', 'MAP3K14']",0.7292946551863192,0,0,3
109,Zinc homeostasis WP3529,0.1713830958964297,2.2950207468879666,4.048081298169806,"['SLC39A11', 'SLC30A10', 'SLC39A1']",0.7292946551863192,0,0,3
110,Fragile X Syndrome  WP4549,0.17138421054480574,1.4077144994123303,2.4829935563107406,"['GABRB2', 'GABRA1', 'GRIN2A', 'GRM5', 'PRKAR1A', 'GAD1', 'CAMK4', 'ITPR1', 'SLC6A1', 'GABRD', 'GABRG2', 'GRM1']",0.7292946551863192,0,0,12
111,Neural Crest Differentiation WP2064,0.1812991616407298,1.5764297385620916,2.6919221182542463,"['SMAD1', 'NOTCH1', 'HES1', 'BMP7', 'FGFR3', 'HES5', 'GFAP']",0.7292946551863192,0,0,7
112,Alpha 6 Beta 4 signaling pathway WP244,0.1834244141042566,1.91294565593631,3.2442651752666163,"['IRS1', 'IRS2', 'LAMB1', 'HRAS']",0.7292946551863192,0,0,4
113,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.18890754798321605,2.8676165803108806,4.778875998867089,"['NOTCH1', 'VEGFA']",0.7292946551863192,0,0,2
114,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.18890754798321605,2.8676165803108806,4.778875998867089,"['SMAD1', 'RUNX2']",0.7292946551863192,0,0,2
115,Computational Model of Aerobic Glycolysis WP4629,0.18890754798321605,2.8676165803108806,4.778875998867089,"['TPI1', 'PGK1']",0.7292946551863192,0,0,2
116,Ganglio Sphingolipid Metabolism WP1423,0.18890754798321605,2.8676165803108806,4.778875998867089,"['ST8SIA1', 'ST8SIA3']",0.7292946551863192,0,0,2
117,ID signaling pathway WP53,0.18890754798321605,2.8676165803108806,4.778875998867089,"['ID2', 'ELK3']",0.7292946551863192,0,0,2
118,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.18890754798321605,2.8676165803108806,4.778875998867089,"['IFIH1', 'SAMHD1']",0.7292946551863192,0,0,2
119,Serotonin and anxiety WP3947,0.18890754798321605,2.8676165803108806,4.778875998867089,"['GABRA1', 'GRM1']",0.7292946551863192,0,0,2
120,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.19214150700420612,2.15138744813278,3.548763427787893,"['BCL6', 'H2AFJ', 'H2AFZ']",0.7292946551863192,0,0,3
121,Prostaglandin Synthesis and Regulation WP98,0.19214150700420612,2.15138744813278,3.548763427787893,"['ABCC4', 'EDNRA', 'S100A6']",0.7292946551863192,0,0,3
122,Head and Neck Squamous Cell Carcinoma WP4674,0.1925174945878516,1.5459735576923077,2.5470969465320006,"['FKBP1A', 'NOTCH1', 'SESN1', 'HRAS', 'FGFR3', 'IGF1R', 'VEGFA']",0.7292946551863192,0,0,7
123,Development of ureteric collection system WP5053,0.20022923891957106,1.8362616822429907,2.9532456606160085,"['SMAD1', 'SPRY1', 'FREM1', 'GLI3']",0.7292946551863192,0,0,4
124,Metabolic reprogramming in colon cancer WP4290,0.20037664197373614,1.6881191145897028,2.713746810836206,"['MDH2', 'PGAM1', 'FASN', 'PGK1', 'SLC16A3']",0.7292946551863192,0,0,5
125,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.20811000696290416,1.4583974709105054,2.2892296793924296,"['MRAS', 'EGF', 'HGF', 'PLCG2', 'HRAS', 'FGFR3', 'IGF1R', 'VEGFA']",0.7292946551863192,0,0,8
126,IL-1 signaling pathway WP195,0.21007753125296064,1.565556711758585,2.442704665689038,"['IL1R1', 'TRAF6', 'TOLLIP', 'TAB2', 'IL1RAP', 'MAP3K14']",0.7292946551863192,0,0,6
127,Cell migration and invasion through p75NTR WP4561,0.21348218108389258,2.0246521845252623,3.1264717719721493,"['ARF1', 'PAK1', 'PARD3']",0.7292946551863192,0,0,3
128,Endothelin Pathways WP2197,0.21348218108389258,2.0246521845252623,3.1264717719721493,"['EDNRA', 'CALCRL', 'GNAI1']",0.7292946551863192,0,0,3
129,Fatty Acid Biosynthesis WP357,0.21348218108389258,2.0246521845252623,3.1264717719721493,"['ACSS2', 'FASN', 'ACSL6']",0.7292946551863192,0,0,3
130,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.21747076770396612,1.7654764757568495,2.6935712852623706,"['MAP1LC3A', 'IRS1', 'FBXO32', 'IGF1R']",0.7292946551863192,0,0,4
131,Neural Crest Cell Migration in Cancer WP4565,0.21747076770396612,1.7654764757568495,2.6935712852623706,"['ARF1', 'PAK1', 'PAK3', 'EPHB1']",0.7292946551863192,0,0,4
132,BMP Signaling Pathway in Eyelid Development WP3927,0.2192671598487331,2.548762233736327,3.867655914670791,"['SMAD1', 'NOTCH1']",0.7292946551863192,0,0,2
133,Cell Differentiation - Index expanded WP2023,0.2192671598487331,2.548762233736327,3.867655914670791,"['ID2', 'RUNX2']",0.7292946551863192,0,0,2
134,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.2192671598487331,2.548762233736327,3.867655914670791,"['SYTL4', 'TBC1D10A']",0.7292946551863192,0,0,2
135,GPR40 Pathway WP3958,0.2192671598487331,2.548762233736327,3.867655914670791,"['PLCG2', 'PLCE1']",0.7292946551863192,0,0,2
136,Kynurenine Pathway and links to Cellular Senescence WP5044,0.2192671598487331,2.548762233736327,3.867655914670791,"['AADAT', 'HAAO']",0.7292946551863192,0,0,2
137,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.2192671598487331,2.548762233736327,3.867655914670791,"['TRAF6', 'MAP3K14']",0.7292946551863192,0,0,2
138,Tryptophan catabolism leading to NAD+ production WP4210,0.2192671598487331,2.548762233736327,3.867655914670791,"['AADAT', 'HAAO']",0.7292946551863192,0,0,2
139,Type II diabetes mellitus WP1584,0.2192671598487331,2.548762233736327,3.867655914670791,"['IRS1', 'CACNA1A']",0.7292946551863192,0,0,2
140,Benzo(a)pyrene metabolism WP696,0.22206196852858334,5.7324016563147,8.626111125201703,['EPHX1'],0.7292946551863192,0,0,1
141,Hypothetical Craniofacial Development Pathway WP3655,0.22206196852858334,5.7324016563147,8.626111125201703,['ARHGAP29'],0.7292946551863192,0,0,1
142,Macrophage markers WP4146,0.22206196852858334,5.7324016563147,8.626111125201703,['F3'],0.7292946551863192,0,0,1
143,Metabolism of alpha-linolenic acid WP4586,0.22206196852858334,5.7324016563147,8.626111125201703,['ALOX12'],0.7292946551863192,0,0,1
144,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.22206196852858334,5.7324016563147,8.626111125201703,['VEGFA'],0.7292946551863192,0,0,1
145,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.22322226343229057,1.5306278182448838,2.2953100478110735,"['PAK1', 'DAAM1', 'TMSB4X', 'NEFL', 'NEFM', 'PFN2']",0.7292946551863192,0,0,6
146,p53 transcriptional gene network WP4963,0.22322226343229057,1.5306278182448838,2.2953100478110735,"['NOTCH1', 'GLS2', 'SESN1', 'FAS', 'SAT1', 'CX3CL1']",0.7292946551863192,0,0,6
147,Senescence and Autophagy in Cancer WP615,0.23000921239155703,1.413267024945857,2.076987980150603,"['GABARAPL1', 'CEBPB', 'MAP1LC3A', 'IRF7', 'COL10A1', 'SLC39A1', 'HRAS', 'IGF1R']",0.7432765377484694,0,0,8
148,miRNAs involvement in the immune response in sepsis WP4329,0.23529299203358256,1.9119986168741356,2.766516240853555,"['TRAF6', 'IRF7', 'TAB2']",0.7432765377484694,0,0,3
149,NRF2-ARE regulation WP4357,0.23529299203358256,1.9119986168741356,2.766516240853555,"['NQO1', 'CEBPB', 'GCLM']",0.7432765377484694,0,0,3
150,SARS-CoV-2 mitochondrial interactions WP5038,0.23529299203358256,1.9119986168741356,2.766516240853555,"['IFIH1', 'TRAF6', 'IRF7']",0.7432765377484694,0,0,3
151,TLR4 Signaling and Tolerance WP3851,0.23529299203358256,1.9119986168741356,2.766516240853555,"['TRAF6', 'IRF7', 'TAB2']",0.7432765377484694,0,0,3
152,Cysteine and methionine catabolism WP4504,0.24998453948849714,2.293678756476684,3.179855776497501,"['BHMT', 'SQOR']",0.7787046530057793,0,0,2
153,Oncostatin M Signaling Pathway WP2374,0.25027129129084685,1.465229038900082,2.0296496009580047,"['SOCS3', 'CEBPB', 'IRS1', 'OSMR', 'HRAS', 'VEGFA']",0.7787046530057793,0,0,6
154,G Protein Signaling Pathways WP35,0.2526797281680389,1.3708309339641729,1.8857595693412423,"['AKAP10', 'PRKAR1A', 'PRKAR2B', 'ITPR1', 'PRKCQ', 'PDE8B', 'HRAS', 'GNAI1']",0.7787046530057793,0,0,8
155,NO/cGMP/PKG mediated Neuroprotection WP4008,0.2530381996140373,1.639074321317312,2.252440215298017,"['GUCY1A2', 'GRIN2A', 'NEFL', 'CYCS']",0.7787046530057793,0,0,4
156,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.25746681330977444,1.8112033195020747,2.457557391488876,"['ITPR1', 'P3H2', 'TNFRSF11B']",0.7794694173405708,0,0,3
157,Regulation of Actin Cytoskeleton WP51,0.2580771791722308,1.2890551618136794,1.7460208270787094,"['PAK1', 'MRAS', 'FGF9', 'EGF', 'TMSB4X', 'CFL1', 'PIP4K2A', 'PIK3C2A', 'PAK3', 'FGFR3', 'ACTB']",0.7794694173405708,0,0,11
158,Glucocorticoid Receptor Pathway WP2880,0.26087443325970777,1.5098752598752598,2.0288436746177636,"['HSP90AA1', 'ENC1', 'SPINK13', 'SPRY1', 'SLC19A2']",0.7794694173405708,0,0,5
159,IL-4 signaling pathway WP395,0.26087443325970777,1.5098752598752598,2.0288436746177636,"['SOCS3', 'CEBPB', 'IRS1', 'FLNA', 'IRS2']",0.7794694173405708,0,0,5
160,Ras signaling WP4223,0.26980674776986213,1.244243535988819,1.630020404774898,"['PLA2G5', 'ETS2', 'IGF1R', 'GRIN2A', 'PAK1', 'MRAS', 'GNG2', 'PLCG2', 'PLCE1', 'CALM3', 'PAK3', 'FGFR3', 'HRAS']",0.7794694173405708,0,0,13
161,Phosphoinositides metabolism WP4971,0.2712528725458555,1.5824112865685538,2.064577993671995,"['PLCG2', 'PIP4K2A', 'PLCE1', 'PIK3C2A']",0.7794694173405708,0,0,4
162,Alzheimer's disease WP2059,0.27768170266127024,1.3616878531073446,1.7447031070143135,"['GRIN2A', 'ITPR1', 'FAS', 'CYCS', 'CALM3', 'SNCA', 'CDK5R1']",0.7794694173405708,0,0,7
163,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.2781756117252736,1.4051689354201617,1.7979174016844268,"['GNG2', 'APEX1', 'HRAS', 'GNAI1', 'IGF1R', 'MYL12B']",0.7794694173405708,0,0,6
164,MTHFR deficiency WP4288,0.27990217676695184,1.72048755186722,2.1907227886960507,"['GRIN2A', 'BHMT', 'CYCS']",0.7794694173405708,0,0,3
165,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.2808068247025866,2.0849740932642487,2.648101207140344,"['BCL2L14', 'BCL2L2']",0.7794694173405708,0,0,2
166,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.2808068247025866,2.0849740932642487,2.648101207140344,"['ITPR1', 'F3']",0.7794694173405708,0,0,2
167,Osteoblast Signaling WP322,0.2845372672570774,3.821256038647343,4.80290248369884,['TNFRSF11B'],0.7794694173405708,0,0,1
168,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.2845372672570774,3.821256038647343,4.80290248369884,['VEGFA'],0.7794694173405708,0,0,1
169,Somatic sex determination WP4814,0.2845372672570774,3.821256038647343,4.80290248369884,['FGF9'],0.7794694173405708,0,0,1
170,Synthesis and Degradation of Ketone Bodies WP311,0.2845372672570774,3.821256038647343,4.80290248369884,['BDH1'],0.7794694173405708,0,0,1
171,The alternative pathway of fetal androgen synthesis WP4524,0.2845372672570774,3.821256038647343,4.80290248369884,['HSD17B6'],0.7794694173405708,0,0,1
172,VEGFA-VEGFR2 Signaling Pathway WP3888,0.2868960552089406,1.1286768806797678,1.4093058020533242,"['EPB41', 'ARPC5L', 'PLOD3', 'HSPB1', 'NRARP', 'PLA2G5', 'RPL10A', 'NDRG1', 'APOLD1', 'RPL7', 'TUBA1C', 'PAK1', 'TMSB4X', 'CFL1', 'PGK1', 'ELOC', 'ATP6V1E1', 'TMSB10', 'HRAS', 'HSP90AA1', 'RPL13A', 'NFATC1', 'F3', 'RAB11A', 'EPN1', 'VEGFA', 'DNAJA1', 'RCAN2', 'TXNIP', 'FAS', 'CYCS', 'HSPA1A']",0.7794694173405708,0,0,32
173,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.28968258580242023,1.5295257874697128,1.8950357804912237,"['ACTA2', 'PAK1', 'PAK3', 'ACTB']",0.7794694173405708,0,0,4
174,Nephrotic syndrome WP4758,0.28968258580242023,1.5295257874697128,1.8950357804912237,"['CUBN', 'PLCE1', 'COQ8B', 'SYNPO']",0.7794694173405708,0,0,4
175,MECP2 and Associated Rett Syndrome WP3584,0.2923889210409452,1.3769406867845995,1.6931832623219965,"['MPP1', 'BCL6', 'GAD1', 'NREP', 'IGF1R', 'GRIA4']",0.7794694173405708,0,0,6
176,Toll-like Receptor Signaling Pathway WP75,0.2923889210409452,1.3769406867845995,1.6931832623219965,"['IFNAR2', 'TICAM2', 'TOLLIP', 'TRAF6', 'IRF7', 'TAB2']",0.7794694173405708,0,0,6
177,Neovascularisation processes WP4331,0.3025037348351368,1.6384113811499703,1.958985663597608,"['SMAD1', 'NOTCH1', 'SMAD9']",0.7794694173405708,0,0,3
178,Sphingolipid pathway WP1422,0.3025037348351368,1.6384113811499703,1.958985663597608,"['UGCG', 'SERINC1', 'B4GALT6']",0.7794694173405708,0,0,3
179,NAD+ metabolism WP3644,0.31151937596394863,1.9110535405872193,2.2288497822573996,"['NT5E', 'CD38']",0.7794694173405708,0,0,2
180,Nanomaterial induced apoptosis WP2507,0.31151937596394863,1.9110535405872193,2.2288497822573996,"['FAS', 'CYCS']",0.7794694173405708,0,0,2
181,SARS coronavirus and innate immunity WP4912,0.31151937596394863,1.9110535405872193,2.2288497822573996,"['IFIH1', 'IFNAR2']",0.7794694173405708,0,0,2
182,Focal Adhesion WP306,0.3150146067921286,1.1939287211740042,1.379150370175518,"['VASP', 'EGF', 'HGF', 'LAMB1', 'ACTB', 'MYL12B', 'VEGFA', 'IGF1R', 'PAK1', 'FLNA', 'TNR', 'PAK3', 'HRAS']",0.7794694173405708,0,0,13
183,Nonalcoholic fatty liver disease WP4396,0.32119171355245235,1.1977600728431597,1.3603165912112338,"['COX8A', 'SOCS3', 'COX7A2L', 'NDUFA5', 'IRS1', 'COX4I1', 'NDUFS3', 'CYCS', 'UQCRFS1', 'FAS', 'IRS2', 'UQCRH']",0.7794694173405708,0,0,12
184,Rett syndrome causing genes WP4312,0.32490442664526964,1.3655826155826156,1.5352210395975041,"['GRIN2A', 'IMPDH2', 'SMARCA1', 'GABRD', 'SYNE2']",0.7794694173405708,0,0,5
185,Resistin as a regulator of inflammation WP4481,0.32518255790680034,1.5637966804979253,1.7567199902620736,"['ITPR1', 'PLCG2', 'PLCE1']",0.7794694173405708,0,0,3
186,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.32697987451157046,1.4336708203530633,1.6026384687795412,"['IFNAR2', 'TRAF6', 'CXCL17', 'IRF7']",0.7794694173405708,0,0,4
187,Hippo-Merlin Signaling Dysregulation WP4541,0.3300521475818656,1.2747685185185185,1.4130867845986996,"['PAK1', 'PRKAR1A', 'PRKAR2B', 'PAK3', 'FGFR3', 'HRAS', 'IGF1R']",0.7794694173405708,0,0,7
188,Pathways in clear cell renal cell carcinoma WP4018,0.3300521475818656,1.2747685185185185,1.4130867845986996,"['TPI1', 'MDH1', 'FASN', 'PGK1', 'ENPP3', 'ENO2', 'VEGFA']",0.7794694173405708,0,0,7
189,Translation Factors WP107,0.3412116076306004,1.3337040081226128,1.4340684942049886,"['EIF4A2', 'EIF5A', 'EEF1A2', 'EIF4H', 'EIF4B']",0.7794694173405708,0,0,5
190,Cardiac Progenitor Differentiation WP2406,0.34194127896005555,1.7638899960143484,1.8928590278285438,"['NOTCH1', 'THY1']",0.7794694173405708,0,0,2
191,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.34194127896005555,1.7638899960143484,1.8928590278285438,"['ITPR1', 'PRKCQ']",0.7794694173405708,0,0,2
192,Mitochondrial complex III assembly WP4921,0.34194127896005555,1.7638899960143484,1.8928590278285438,"['UQCRFS1', 'UQCRH']",0.7794694173405708,0,0,2
193,Nucleotide metabolism WP404,0.34194127896005555,1.7638899960143484,1.8928590278285438,"['SAT1', 'OAZ1']",0.7794694173405708,0,0,2
194,Pregnane X receptor pathway WP2876,0.34194127896005555,1.7638899960143484,1.8928590278285438,"['ABCC4', 'HSP90AA1']",0.7794694173405708,0,0,2
195,Sleep regulation WP3591,0.34194127896005555,1.7638899960143484,1.8928590278285438,"['GRIN2A', 'IL18']",0.7794694173405708,0,0,2
196,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.3420000137697458,2.8656832298136647,3.0747190649195826,['COX8A'],0.7794694173405708,0,0,1
197,Bile acids synthesis and enterohepatic circulation  WP4389,0.3420000137697458,2.8656832298136647,3.0747190649195826,['SLC10A1'],0.7794694173405708,0,0,1
198,Cytokines and Inflammatory Response WP530,0.3420000137697458,2.8656832298136647,3.0747190649195826,['CSF1'],0.7794694173405708,0,0,1
199,Estrogen metabolism WP697,0.3420000137697458,2.8656832298136647,3.0747190649195826,['NQO1'],0.7794694173405708,0,0,1
200,Liver X receptor pathway WP2874,0.3420000137697458,2.8656832298136647,3.0747190649195826,['FASN'],0.7794694173405708,0,0,1
201,miR-517 relationship with ARCN1 and USP1 WP3596,0.3420000137697458,2.8656832298136647,3.0747190649195826,['ID2'],0.7794694173405708,0,0,1
202,NAD Biosynthesis II (from tryptophan) WP2485,0.3420000137697458,2.8656832298136647,3.0747190649195826,['HAAO'],0.7794694173405708,0,0,1
203,Nephrogenesis WP5052,0.3420000137697458,2.8656832298136647,3.0747190649195826,['BMP7'],0.7794694173405708,0,0,1
204,Serotonin Transporter Activity WP1455,0.3420000137697458,2.8656832298136647,3.0747190649195826,['IL1R1'],0.7794694173405708,0,0,1
205,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.3420000137697458,2.8656832298136647,3.0747190649195826,['IGF1R'],0.7794694173405708,0,0,1
206,Tgif disruption of Shh signaling WP3674,0.3420000137697458,2.8656832298136647,3.0747190649195826,['GLI3'],0.7794694173405708,0,0,1
207,Oxidative Damage WP3941,0.3478562949341028,1.4956702146851886,1.5793766397832036,"['C1R', 'TRAF6', 'CYCS']",0.7794694173405708,0,0,3
208,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.3478562949341028,1.4956702146851886,1.5793766397832036,"['CAMK4', 'ITPR1', 'CALM3']",0.7794694173405708,0,0,3
209,Ectoderm Differentiation WP2858,0.35620292294891615,1.1828200239149405,1.220971531589411,"['ABCC4', 'ELOVL4', 'BOC', 'RHPN1', 'TNFRSF11B', 'NFATC1', 'KIFC3', 'JAKMIP1', 'GLI3', 'SNCA']",0.7794694173405708,0,0,10
210,One-carbon metabolism and related pathways WP3940,0.36453545136503196,1.3490929081913139,1.3614121123107998,"['BHMT', 'GPX4', 'GAD1', 'GCLM']",0.7794694173405708,0,0,4
211,Phosphodiesterases in neuronal function WP4222,0.36453545136503196,1.3490929081913139,1.3614121123107998,"['GUCY1A2', 'GRIN2A', 'PDE10A', 'PDE8B']",0.7794694173405708,0,0,4
212,Folate Metabolism WP176,0.37044922078045417,1.4332209543568464,1.4232441593440337,"['CSF1', 'GPX4', 'RFK']",0.7794694173405708,0,0,3
213,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.37044922078045417,1.4332209543568464,1.4232441593440337,"['IFIH1', 'IFNAR2', 'TRAF6']",0.7794694173405708,0,0,3
214,Intraflagellar transport proteins binding to dynein WP4532,0.37044922078045417,1.4332209543568464,1.4232441593440337,"['DYNLT3', 'IFT27', 'DYNLL2']",0.7794694173405708,0,0,3
215,Microglia Pathogen Phagocytosis Pathway WP3937,0.37192132160410685,1.6377498149518874,1.6198540377946633,"['PLCG2', 'PIK3C2A']",0.7794694173405708,0,0,2
216,Proteoglycan biosynthesis WP4784,0.37192132160410685,1.6377498149518874,1.6198540377946633,"['XYLT1', 'B4GALT7']",0.7794694173405708,0,0,2
217,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.37192132160410685,1.6377498149518874,1.6198540377946633,"['ITPR1', 'HRAS']",0.7794694173405708,0,0,2
218,Adipogenesis WP236,0.37381830789108395,1.1917175629375838,1.172632691658914,"['SOCS3', 'CEBPB', 'KLF6', 'IRS1', 'PNPLA3', 'FAS', 'IRS2', 'RXRG']",0.7794694173405708,0,0,8
219,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.37396321186240805,1.2741972741972742,1.2532976998986152,"['PLCG2', 'PLCE1', 'PRKCQ', 'HRAS', 'RXRG']",0.7794694173405708,0,0,5
220,Notch Signaling Pathway Netpath WP61,0.37396321186240805,1.2741972741972742,1.2532976998986152,"['HES6', 'NUMBL', 'NOTCH1', 'HES1', 'HES5']",0.7794694173405708,0,0,5
221,PI3K-Akt signaling pathway WP4172,0.3814741059565181,1.1083552631578948,1.068135605257207,"['IFNAR2', 'HSP90AA1', 'CSF1', 'IRS1', 'EGF', 'HGF', 'LPAR3', 'LAMB1', 'OSMR', 'VEGFA', 'IGF1R', 'GNG2', 'FGF9', 'TNR', 'HRAS', 'FGFR3', 'EIF4B']",0.7794694173405708,0,0,17
222,Regulation of Microtubule Cytoskeleton WP2038,0.3832964534181656,1.3104287197745141,1.2566311121609954,"['PAK1', 'PARD6A', 'CAMK4', 'STMN1']",0.7794694173405708,0,0,4
223,22q11.2 copy number variation syndrome WP4657,0.3837121835441825,1.1982276119402986,1.1477373312261727,"['RTN4R', 'ACTA2', 'RANBP1', 'OAT', 'THAP7', 'HES1', 'RAN']",0.7794694173405708,0,0,7
224,Allograft Rejection WP2328,0.3928921915069944,1.3757676348547718,1.2852696764447913,"['TUBA1B', 'FAS', 'VEGFA']",0.7794694173405708,0,0,3
225,Prader-Willi and Angelman Syndrome WP3998,0.3928921915069944,1.3757676348547718,1.2852696764447913,"['SNRPN', 'GABRD', 'GABRG2']",0.7794694173405708,0,0,3
226,Cellular Proteostasis WP4918,0.3948519933504696,2.2923395445134576,2.130143420278898,['PFDN5'],0.7794694173405708,0,0,1
227,Complement Activation WP545,0.3948519933504696,2.2923395445134576,2.130143420278898,['C1R'],0.7794694173405708,0,0,1
228,Fluoroacetic acid toxicity WP4966,0.3948519933504696,2.2923395445134576,2.130143420278898,['ACSS2'],0.7794694173405708,0,0,1
229,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.3948519933504696,2.2923395445134576,2.130143420278898,['CEBPB'],0.7794694173405708,0,0,1
230,Genes targeted by miRNAs in adipocytes WP1992,0.3948519933504696,2.2923395445134576,2.130143420278898,['TMSB4X'],0.7794694173405708,0,0,1
231,HIF1A and PPARG regulation of glycolysis WP2456,0.3948519933504696,2.2923395445134576,2.130143420278898,['TPI1'],0.7794694173405708,0,0,1
232,Insulin signaling in adipocytes (diabetic condition) WP3635,0.3948519933504696,2.2923395445134576,2.130143420278898,['IRS1'],0.7794694173405708,0,0,1
233,Insulin signaling in adipocytes (normal condition) WP3634,0.3948519933504696,2.2923395445134576,2.130143420278898,['IRS1'],0.7794694173405708,0,0,1
234,LDLRAD4 and what we know about it WP4904,0.3948519933504696,2.2923395445134576,2.130143420278898,['NEDD4'],0.7794694173405708,0,0,1
235,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.3948519933504696,2.2923395445134576,2.130143420278898,['SOCS3'],0.7794694173405708,0,0,1
236,miRNA Biogenesis WP2338,0.3948519933504696,2.2923395445134576,2.130143420278898,['RAN'],0.7794694173405708,0,0,1
237,"Phase I biotransformations, non P450 WP136",0.3948519933504696,2.2923395445134576,2.130143420278898,['PON1'],0.7794694173405708,0,0,1
238,Sulfation Biotransformation Reaction WP692,0.3948519933504696,2.2923395445134576,2.130143420278898,['SULT4A1'],0.7794694173405708,0,0,1
239,Urea cycle and related diseases WP4571,0.3948519933504696,2.2923395445134576,2.130143420278898,['GLS2'],0.7794694173405708,0,0,1
240,Canonical and non-canonical Notch signaling WP3845,0.40133439868692894,1.5284283246977548,1.395394362356283,"['NOTCH1', 'HES1']",0.7794694173405708,0,0,2
241,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.40133439868692894,1.5284283246977548,1.395394362356283,"['FLNA', 'RUNX2']",0.7794694173405708,0,0,2
242,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.40133439868692894,1.5284283246977548,1.395394362356283,"['MRAS', 'HRAS']",0.7794694173405708,0,0,2
243,Ovarian infertility WP34,0.40133439868692894,1.5284283246977548,1.395394362356283,"['CEBPB', 'SYNE2']",0.7794694173405708,0,0,2
244,Striated Muscle Contraction Pathway WP383,0.40133439868692894,1.5284283246977548,1.395394362356283,"['ACTA2', 'TCAP']",0.7794694173405708,0,0,2
245,Urea cycle and metabolism of amino groups WP497,0.40133439868692894,1.5284283246977548,1.395394362356283,"['ARG2', 'OAT']",0.7794694173405708,0,0,2
246,Cytosolic DNA-sensing pathway WP4655,0.40199051711903655,1.2739125418253143,1.1609506146126711,"['RNF125', 'IL18', 'IRF7', 'POLR2L']",0.7794694173405708,0,0,4
247,TNF-alpha signaling pathway WP231,0.4106864089077314,1.1632850241545893,1.035236833519115,"['HSP90AA1', 'RFK', 'OTUD7B', 'TAB2', 'RFFL', 'HRAS', 'MAP3K14']",0.7893501039147198,0,0,7
248,Fatty acid beta-oxidation WP143,0.41512252523773807,1.3227338014682413,1.162923168084441,"['ACSS2', 'TPI1', 'ACSL6']",0.7893501039147198,0,0,3
249,Gastric Cancer Network 2 WP2363,0.4300783016903449,1.4327720207253887,1.2089558233784496,"['S100A6', 'CACYBP']",0.7893501039147198,0,0,2
250,Genes controlling nephrogenesis WP4823,0.4300783016903449,1.4327720207253887,1.2089558233784496,"['GLI3', 'VEGFA']",0.7893501039147198,0,0,2
251,Insulin Signaling WP481,0.4306026007625367,1.0920967339815508,0.9201675675178214,"['SOCS3', 'SNAP25', 'ARF1', 'IRS1', 'FLOT2', 'IRS2', 'PRKCQ', 'PIK3C2A', 'MAP3K14', 'HRAS', 'SH2B2', 'IGF1R']",0.7893501039147198,0,0,12
252,Type 2 papillary renal cell carcinoma WP4241,0.4370838238227659,1.2736284001844167,1.0540934367876587,"['EGLN3', 'ELOC', 'VEGFA']",0.7893501039147198,0,0,3
253,ESC Pluripotency Pathways WP3931,0.4375869382092033,1.1303110328638497,0.9341793234346555,"['SMAD1', 'FGF9', 'EGF', 'WNT7B', 'SMAD9', 'FGFR3', 'HRAS']",0.7893501039147198,0,0,7
254,PPAR signaling pathway WP3942,0.4390259427021109,1.2066458982346833,0.9933070091697197,"['FABP3', 'ACSL6', 'DBI', 'RXRG']",0.7893501039147198,0,0,4
255,Apoptosis WP254,0.43920705413566274,1.1697568840425983,0.9624576312771078,"['IRF7', 'FAS', 'CYCS', 'BCL2L2', 'IGF1R']",0.7893501039147198,0,0,5
256,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.44346281720606995,1.9101104209799862,1.5531897094289062,['TRAF6'],0.7893501039147198,0,0,1
257,"Cerebral organic acidurias, including diseases WP4519",0.44346281720606995,1.9101104209799862,1.5531897094289062,['MDH2'],0.7893501039147198,0,0,1
258,Dual hijack model of Vif in HIV infection WP3300,0.44346281720606995,1.9101104209799862,1.5531897094289062,['ELOC'],0.7893501039147198,0,0,1
259,Glial Cell Differentiation WP2276,0.44346281720606995,1.9101104209799862,1.5531897094289062,['PLP1'],0.7893501039147198,0,0,1
260,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.44346281720606995,1.9101104209799862,1.5531897094289062,['TRAF6'],0.7893501039147198,0,0,1
261,Ketogenesis and Ketolysis WP4742,0.44346281720606995,1.9101104209799862,1.5531897094289062,['BDH1'],0.7893501039147198,0,0,1
262,LTF danger signal response pathway WP4478,0.44346281720606995,1.9101104209799862,1.5531897094289062,['TRAF6'],0.7893501039147198,0,0,1
263,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.44346281720606995,1.9101104209799862,1.5531897094289062,['BHMT'],0.7893501039147198,0,0,1
264,Osteoclast Signaling WP12,0.44346281720606995,1.9101104209799862,1.5531897094289062,['TNFRSF11B'],0.7893501039147198,0,0,1
265,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.44346281720606995,1.9101104209799862,1.5531897094289062,['TRAF6'],0.7893501039147198,0,0,1
266,Transcriptional cascade regulating adipogenesis WP4211,0.44346281720606995,1.9101104209799862,1.5531897094289062,['CEBPB'],0.7893501039147198,0,0,1
267,Vitamin B12 Disorders WP4271,0.44346281720606995,1.9101104209799862,1.5531897094289062,['CUBN'],0.7893501039147198,0,0,1
268,Amino Acid metabolism WP3925,0.45315670789332946,1.1275140308080722,0.8924468385800658,"['ARG2', 'BHMT', 'OAT', 'MDH1', 'MDH2', 'GCLM']",0.7893501039147198,0,0,6
269,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.4572978853664773,1.1755997550390074,0.9198130806886604,"['BEX3', 'SOCS3', 'NQO1', 'HSPB1']",0.7893501039147198,0,0,4
270,Selenium Micronutrient Network WP15,0.4572978853664773,1.1755997550390074,0.9198130806886604,"['PRDX3', 'GPX4', 'RFK', 'SEPHS2']",0.7893501039147198,0,0,4
271,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.4572978853664773,1.1755997550390074,0.9198130806886604,"['GRIN2A', 'CAMK4', 'HRAS', 'GRM1']",0.7893501039147198,0,0,4
272,Cannabinoid receptor signaling WP3869,0.4580708545499315,1.3483693995733008,1.052714332519327,"['PRKAR2B', 'PRKAR1A']",0.7893501039147198,0,0,2
273,"GPCRs, Other WP117",0.4580708545499315,1.3483693995733008,1.052714332519327,"['EDNRA', 'GRM1']",0.7893501039147198,0,0,2
274,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.4580708545499315,1.3483693995733008,1.052714332519327,"['CEBPB', 'ATP2C2']",0.7893501039147198,0,0,2
275,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.4580708545499315,1.3483693995733008,1.052714332519327,"['MDH1', 'MDH2']",0.7893501039147198,0,0,2
276,TYROBP causal network in microglia WP3945,0.4580708545499315,1.3483693995733008,1.052714332519327,"['ABCC4', 'IL18']",0.7893501039147198,0,0,2
277,Signaling of Hepatocyte Growth Factor Receptor WP313,0.4587257486952887,1.2280305275637227,0.9570075609393459,"['PAK1', 'HGF', 'HRAS']",0.7893501039147198,0,0,3
278,Glioblastoma signaling pathways WP2261,0.46762646385194095,1.1092276190795878,0.8431077805689757,"['IRS1', 'PLCG2', 'PRKCQ', 'PIK3C2A', 'HRAS', 'IGF1R']",0.7893501039147198,0,0,6
279,RANKL/RANK signaling pathway WP2018,0.47536405720730485,1.1461059190031153,0.8523295540412065,"['TRAF6', 'TNFRSF11B', 'NFATC1', 'TAB2']",0.7893501039147198,0,0,4
280,Amyotrophic lateral sclerosis (ALS) WP2447,0.48000376169027553,1.1855773358134212,0.8701679279998006,"['SLC1A2', 'NEFL', 'NEFM']",0.7893501039147198,0,0,3
281,Disruption of postsynaptic signaling by CNV WP4875,0.48000376169027553,1.1855773358134212,0.8701679279998006,"['GRIN2A', 'GRM1', 'YWHAG']",0.7893501039147198,0,0,3
282,Parkinson's disease pathway WP2371,0.48000376169027553,1.1855773358134212,0.8701679279998006,"['UCHL1', 'CYCS', 'SNCA']",0.7893501039147198,0,0,3
283,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.48000376169027553,1.1855773358134212,0.8701679279998006,"['HSP90AA1', 'TRAF6', 'FAS']",0.7893501039147198,0,0,3
284,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.4852473613706481,1.2733448474381117,0.920751195622097,"['HGF', 'HRAS']",0.7893501039147198,0,0,2
285,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.4852473613706481,1.2733448474381117,0.920751195622097,"['FGF9', 'FGFR3']",0.7893501039147198,0,0,2
286,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.4852473613706481,1.2733448474381117,0.920751195622097,"['TICAM2', 'TRAF6']",0.7893501039147198,0,0,2
287,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.4858663532693652,1.0661299318573125,0.7695557050918315,"['CLDN20', 'PAK1', 'NOTCH1', 'ID2', 'TRAF6', 'WNT7B', 'EIF5A2', 'HRAS']",0.7893501039147198,0,0,8
288,Melanoma WP4685,0.48710383958797915,1.1019710538941307,0.7926234868360349,"['GRM3', 'GRIN2A', 'PAK1', 'CALM3', 'HRAS']",0.7893501039147198,0,0,5
289,Autosomal recessive Osteopetrosis pathways WP4788,0.48817249613174496,1.6370896184560781,1.1739347990491622,['TRAF6'],0.7893501039147198,0,0,1
290,Biomarkers for urea cycle disorders WP4583,0.48817249613174496,1.6370896184560781,1.1739347990491622,['GLS2'],0.7893501039147198,0,0,1
291,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.48817249613174496,1.6370896184560781,1.1739347990491622,['ELOC'],0.7893501039147198,0,0,1
292,Inflammatory Response Pathway WP453,0.48817249613174496,1.6370896184560781,1.1739347990491622,['LAMB1'],0.7893501039147198,0,0,1
293,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.48817249613174496,1.6370896184560781,1.1739347990491622,['EGF'],0.7893501039147198,0,0,1
294,Thiamine metabolic pathways WP4297,0.48817249613174496,1.6370896184560781,1.1739347990491622,['SLC19A2'],0.7893501039147198,0,0,1
295,Trans-sulfuration pathway WP2333,0.48817249613174496,1.6370896184560781,1.1739347990491622,['GCLM'],0.7893501039147198,0,0,1
296,7q11.23 copy number variation syndrome WP4932,0.4907030169414289,1.0696388888888888,0.7614932399560636,"['CLIP2', 'SNAP25', 'ABHD11', 'CFL1', 'EIF4H', 'ATP5MC3', 'FAS']",0.7907612806792621,0,0,7
297,Proteasome Degradation WP183,0.5027533389728586,1.0810810810810811,0.7434114691173095,"['PSMD10', 'UCHL1', 'UBE2B', 'H2AFZ', 'NEDD4']",0.8074523322897424,0,0,5
298,EPO Receptor Signaling WP581,0.511558334083315,1.206217616580311,0.808520014900108,"['IRS1', 'IRS2']",0.8133777511924708,0,0,2
299,Trans-sulfuration and one-carbon metabolism WP2525,0.511558334083315,1.206217616580311,0.808520014900108,"['BHMT', 'GCLM']",0.8133777511924708,0,0,2
300,Tryptophan metabolism WP465,0.511558334083315,1.206217616580311,0.808520014900108,"['AADAT', 'HAAO']",0.8133777511924708,0,0,2
301,G13 Signaling Pathway WP524,0.5213171771976239,1.108887699103199,0.7223257180678403,"['CFL1', 'PIP4K2A', 'PAK3']",0.8250756429000411,0,0,3
302,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.527150166061987,1.0209388370987411,0.65367633152537,"['SLCO1C1', 'IRS1', 'FASN', 'TRIP10', 'FLOT2', 'IRS2', 'PIK3C2A', 'MAP3K14', 'HRAS']",0.8250756429000411,0,0,9
303,Dopamine metabolism WP2436,0.5292938086528566,1.432324016563147,0.9112611506047544,['NQO1'],0.8250756429000411,0,0,1
304,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.5292938086528566,1.432324016563147,0.9112611506047544,['PRKCQ'],0.8250756429000411,0,0,1
305,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.5292938086528566,1.432324016563147,0.9112611506047544,['PRKCQ'],0.8250756429000411,0,0,1
306,NLR Proteins WP288,0.5292938086528566,1.432324016563147,0.9112611506047544,['ERBIN'],0.8250756429000411,0,0,1
307,Chemokine signaling pathway WP3929,0.5341590043028233,1.0183756227551848,0.6385843731520339,"['PAK1', 'GNG2', 'GRK5', 'PARD3', 'PRKX', 'HRAS', 'CX3CL1', 'GNAI1']",0.829947378020999,0,0,8
308,EGF/EGFR signaling pathway WP437,0.5557109252452825,0.9920765657430897,0.5828519651642006,"['PLSCR1', 'PAK1', 'EGF', 'LIMK2', 'NEDD4', 'CFL1', 'STMN1', 'PEBP1', 'PLCE1', 'HRAS', 'EPN1']",0.858773354953231,0,0,11
309,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.5614498653752973,1.0911423636812239,0.6298431571424434,"['ACTA2', 'PRKCQ']",0.858773354953231,0,0,2
310,Non-small cell lung cancer WP4255,0.5632902025065158,1.0048510048510049,0.5767446105891524,"['EGF', 'PLCG2', 'CYCS', 'HRAS', 'RXRG']",0.858773354953231,0,0,5
311,Galanin receptor pathway WP4970,0.567114479686096,1.2730618817575339,0.7220731773525566,['VEGFA'],0.858773354953231,0,0,1
312,Matrix Metalloproteinases WP129,0.567114479686096,1.2730618817575339,0.7220731773525566,['TIMP2'],0.858773354953231,0,0,1
313,miR-509-3p alteration of YAP1/ECM axis WP3967,0.567114479686096,1.2730618817575339,0.7220731773525566,['EDNRA'],0.858773354953231,0,0,1
314,Osteopontin Signaling WP1434,0.567114479686096,1.2730618817575339,0.7220731773525566,['MAP3K14'],0.858773354953231,0,0,1
315,TCA cycle in senescence WP5050,0.567114479686096,1.2730618817575339,0.7220731773525566,['MDH1'],0.858773354953231,0,0,1
316,Breast cancer pathway WP4262,0.5692191214234559,0.9852556987004832,0.5551815561422591,"['NOTCH1', 'FGF9', 'EGF', 'WNT7B', 'HES1', 'HRAS', 'HES5', 'IGF1R']",0.8592326611360395,0,0,8
317,Oxidative phosphorylation WP623,0.5780342163000355,0.9960720574292293,0.5459692217313739,"['ATP6AP1', 'NDUFA5', 'NDUFS3', 'ATP5MC3']",0.8668918184263452,0,0,4
318,Regulatory circuits of the STAT3 signaling pathway WP4538,0.5780342163000355,0.9960720574292293,0.5459692217313739,"['IFNAR2', 'SOCS3', 'STMN1', 'OSMR']",0.8668918184263452,0,0,4
319,Interleukin-11 Signaling Pathway WP2332,0.579745262218038,1.0107700756651208,0.5510379591776899,"['SOCS3', 'HRAS', 'RUNX2']",0.8668918184263452,0,0,3
320,Oxysterols derived from cholesterol WP4545,0.5849904065952143,1.0414507772020725,0.5583840725612658,"['CYP39A1', 'DBP']",0.8692848098003652,0,0,2
321,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.5849904065952143,1.0414507772020725,0.5583840725612658,"['PGK1', 'VEGFA']",0.8692848098003652,0,0,2
322,Androgen receptor signaling pathway WP138,0.5914360063785176,0.967829872052293,0.5083059813389917,"['SUMO1', 'LIMK2', 'FLNA', 'FKBP4', 'RUNX2', 'RAN']",0.8700179141401659,0,0,6
323,IL-3 signaling pathway WP286,0.598191804650808,0.9818020154119739,0.5044929107438169,"['YWHAB', 'ENPP3', 'HRAS']",0.8700179141401659,0,0,3
324,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.598191804650808,0.9818020154119739,0.5044929107438169,"['PAK1', 'PRKCQ', 'MAP3K14']",0.8700179141401659,0,0,3
325,Alanine and aspartate metabolism WP106,0.6018991858831336,1.1456521739130434,0.5816078694674095,['GAD1'],0.8700179141401659,0,0,1
326,Cancer immunotherapy by PD-1 blockade WP4585,0.6018991858831336,1.1456521739130434,0.5816078694674095,['NFATC1'],0.8700179141401659,0,0,1
327,Glycolysis in senescence WP5049,0.6018991858831336,1.1456521739130434,0.5816078694674095,['PGK1'],0.8700179141401659,0,0,1
328,Mammalian disorder of sexual development WP4842,0.6018991858831336,1.1456521739130434,0.5816078694674095,['FGF9'],0.8700179141401659,0,0,1
329,RalA downstream regulated genes WP2290,0.6018991858831336,1.1456521739130434,0.5816078694674095,['HRAS'],0.8700179141401659,0,0,1
330,TP53 network WP1742,0.6018991858831336,1.1456521739130434,0.5816078694674095,['SUMO1'],0.8700179141401659,0,0,1
331,Ebola Virus Pathway on Host WP4217,0.6150505655434635,0.9429411764705883,0.4583173076693689,"['SOCS3', 'PAK1', 'NEDD4', 'IRF7', 'FLNA', 'ACTB', 'IGF1R']",0.8862781412289427,0,0,7
332,MET in type 1 papillary renal cell carcinoma WP4205,0.6248506275378513,0.9348337465827452,0.439598701807428,"['PAK1', 'HGF', 'PAK3', 'HRAS']",0.8862781412289427,0,0,4
333,ErbB signaling pathway WP673,0.6292251705494982,0.9283404111707961,0.4300686459759004,"['PAK1', 'NRG4', 'EGF', 'PLCG2', 'PAK3', 'HRAS']",0.8862781412289427,0,0,6
334,Regulation of toll-like receptor signaling pathway WP1449,0.6292251705494982,0.9283404111707961,0.4300686459759004,"['IFNAR2', 'TICAM2', 'TOLLIP', 'TRAF6', 'IRF7', 'TAB2']",0.8862781412289427,0,0,6
335,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.6292261992962377,0.9544905008635579,0.44218153562594437,"['PRKCQ', 'HRAS']",0.8862781412289427,0,0,2
336,Pathways Regulating Hippo Signaling WP4540,0.6333067646210423,0.9233954798470928,0.42180738205216217,"['PRKAR1A', 'PRKAR2B', 'PRKCQ', 'FGFR3', 'IGF1R']",0.8862781412289427,0,0,5
337,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.6334599307168024,0.9285634181899742,0.4239435509530131,"['EIF4A2', 'PDCD4', 'EIF4B']",0.8862781412289427,0,0,3
338,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.6338913997132912,1.041407867494824,0.4747545536679717,['ALOX12'],0.8862781412289427,0,0,1
339,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.6338913997132912,1.041407867494824,0.4747545536679717,['TRAF6'],0.8862781412289427,0,0,1
340,Pyrimidine metabolism and related diseases WP4225,0.6338913997132912,1.041407867494824,0.4747545536679717,['GLS2'],0.8862781412289427,0,0,1
341,TGF-beta Signaling Pathway WP366,0.6354928184262866,0.9250376549646623,0.41936997344924587,"['EID2', 'KLF6', 'PARD6A', 'SUMO1', 'TRAF6', 'LIMK2', 'RUNX2', 'PJA1']",0.8862781412289427,0,0,8
342,Pathways affected in adenoid cystic carcinoma WP3651,0.6397021019172185,0.9160539979231568,0.40924957561565767,"['MORF4L1', 'NOTCH1', 'ERBIN', 'HRAS']",0.8862781412289427,0,0,4
343,Integrated breast cancer pathway WP1984,0.643789073411814,0.9197453772740829,0.40504126989317,"['BARD1', 'SMAD1', 'ITPKC', 'PAK1', 'RASGEF1A', 'IRS1', 'FILIP1', 'JAKMIP1', 'VEGFA']",0.8862781412289427,0,0,9
344,Corticotropin-releasing hormone signaling pathway WP2355,0.6464559847917685,0.9086559086559086,0.3964012904336611,"['HSP90AA1', 'IL18', 'PLCG2', 'PRKCQ', 'GNAI1']",0.8862781412289427,0,0,5
345,Base Excision Repair WP4752,0.6499283395783988,0.9162279792746114,0.39479637749094687,"['APEX1', 'POLE3']",0.8862781412289427,0,0,2
346,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.6502663043375227,0.904045643153527,0.3890771077125389,"['ELOVL4', 'FASN', 'MSMO1']",0.8862781412289427,0,0,3
347,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.6502663043375227,0.904045643153527,0.3890771077125389,"['CFL1', 'HRAS', 'SYNE2']",0.8862781412289427,0,0,3
348,Modulators of TCR signaling and T cell activation WP5072,0.6502663043375227,0.904045643153527,0.3890771077125389,"['TRAF6', 'PRKCQ', 'MAP3K14']",0.8862781412289427,0,0,3
349,Airway smooth muscle cell contraction WP4962,0.6633150868317245,0.9545376121463078,0.3918426129081965,['CD38'],0.8862781412289427,0,0,1
350,Hedgehog Signaling Pathway Netpath WP47,0.6633150868317245,0.9545376121463078,0.3918426129081965,['GLI3'],0.8862781412289427,0,0,1
351,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.6633150868317245,0.9545376121463078,0.3918426129081965,['FGF9'],0.8862781412289427,0,0,1
352,Omega-3/Omega-6 FA synthesis WP4723,0.6633150868317245,0.9545376121463078,0.3918426129081965,['PLA2G5'],0.8862781412289427,0,0,1
353,Omega-9 FA synthesis WP4724,0.6633150868317245,0.9545376121463078,0.3918426129081965,['FASN'],0.8862781412289427,0,0,1
354,PPAR-alpha pathway WP2878,0.6633150868317245,0.9545376121463078,0.3918426129081965,['DBI'],0.8862781412289427,0,0,1
355,Riboflavin and CoQ disorders WP5037,0.6633150868317245,0.9545376121463078,0.3918426129081965,['RFK'],0.8862781412289427,0,0,1
356,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.6633150868317245,0.9545376121463078,0.3918426129081965,['NQO1'],0.8862781412289427,0,0,1
357,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.6633150868317245,0.9545376121463078,0.3918426129081965,['RUNX2'],0.8862781412289427,0,0,1
358,Pyrimidine metabolism WP4022,0.6840836856140626,0.8671171171171171,0.32922271004495146,"['ENTPD3', 'POLE3', 'POLR2G', 'ENPP3', 'POLR2L']",0.9114746313908042,0,0,5
359,Glycosaminoglycan degradation WP4815,0.6903762671801211,0.8810320114667941,0.32643867279145666,['IDS'],0.9157514525330599,0,0,1
360,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.6911331717230641,0.8800385418339489,0.32510625875388327,"['NSF', 'IRS1', 'TRAF6', 'CAMK4', 'CFL1', 'IRS2', 'HRAS', 'SH2B2', 'CDK5R1']",0.9157514525330599,0,0,9
361,CAMKK2  Pathway WP4874,0.7065203455532388,0.817838638045892,0.2841198250432526,"['MAP1LC3A', 'CAMK4']",0.9208543326646942,0,0,2
362,Pancreatic adenocarcinoma pathway WP4263,0.7076182884798649,0.8414608046960989,0.2910196158359137,"['PAK1', 'EGF', 'PEBP1', 'PAK3', 'VEGFA']",0.9208543326646942,0,0,5
363,Cholesterol Biosynthesis Pathway WP197,0.715264452028139,0.8180272108843537,0.27412332475321666,['MSMO1'],0.9208543326646942,0,0,1
364,Constitutive Androstane Receptor Pathway WP2875,0.715264452028139,0.8180272108843537,0.27412332475321666,['HSP90AA1'],0.9208543326646942,0,0,1
365,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.715264452028139,0.8180272108843537,0.27412332475321666,['PLA2G5'],0.9208543326646942,0,0,1
366,Overview of interferons-mediated signaling pathway WP4558,0.715264452028139,0.8180272108843537,0.27412332475321666,['IFNAR2'],0.9208543326646942,0,0,1
367,Purinergic signaling WP4900,0.715264452028139,0.8180272108843537,0.27412332475321666,['GNAI1'],0.9208543326646942,0,0,1
368,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.715264452028139,0.8180272108843537,0.27412332475321666,['FASN'],0.9208543326646942,0,0,1
369,Statin inhibition of cholesterol production WP430,0.715264452028139,0.8180272108843537,0.27412332475321666,['APOC1'],0.9208543326646942,0,0,1
370,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.715264452028139,0.8180272108843537,0.27412332475321666,['MDH1'],0.9208543326646942,0,0,1
371,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.7236096083391707,0.789565838842237,0.25542711260647283,"['HEXIM1', 'NFATC1']",0.9208543326646942,0,0,2
372,Integrin-mediated Cell Adhesion WP185,0.7298974515430785,0.8172705672705672,0.25731864501991963,"['VASP', 'PAK1', 'CAPNS1', 'PAK3', 'HRAS']",0.9208543326646942,0,0,5
373,Mitochondrial Gene Expression WP391,0.7381539650560198,0.7634230503795721,0.23177741492249102,['CAMK4'],0.9208543326646942,0,0,1
374,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.7381539650560198,0.7634230503795721,0.23177741492249102,['PLP1'],0.9208543326646942,0,0,1
375,"Relationship between inflammation, COX-2 and EGFR WP4483",0.7381539650560198,0.7634230503795721,0.23177741492249102,['HRAS'],0.9208543326646942,0,0,1
376,Hepatitis C and Hepatocellular Carcinoma WP3646,0.7398499780093373,0.7631778929188255,0.22995148684453248,"['UCHL1', 'VEGFA']",0.9208543326646942,0,0,2
377,p38 MAPK Signaling Pathway WP400,0.7398499780093373,0.7631778929188255,0.22995148684453248,"['HSPB1', 'HRAS']",0.9208543326646942,0,0,2
378,Male infertility WP4673,0.7405662034481111,0.805686509911862,0.24198008423082545,"['NQO1', 'BHMT', 'UBE2B', 'PON1', 'FAS']",0.9208543326646942,0,0,5
379,Retinoblastoma gene in cancer WP2446,0.744258349369399,0.7891288000859383,0.23308265415417584,"['BARD1', 'H2AFZ', 'STMN1', 'RBP1']",0.9208543326646942,0,0,4
380,DNA damage response WP707,0.7524110033705159,0.7629322268326417,0.21703328161326055,"['SESN1', 'FAS', 'CYCS']",0.9208543326646942,0,0,3
381,IL-2 signaling pathway WP49,0.7552674503813762,0.7384923951195053,0.20728252202975017,"['SOCS3', 'HRAS']",0.9208543326646942,0,0,2
382,16p11.2 proximal deletion syndrome WP4949,0.7555412947352254,0.7756833342133517,0.21744020377990908,"['TRAF6', 'MVP', 'TCP1', 'SEZ6L2']",0.9208543326646942,0,0,4
383,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.7555412947352254,0.7756833342133517,0.21744020377990908,"['SLCO1C1', 'NOTCH1', 'PRKCQ', 'HRAS']",0.9208543326646942,0,0,4
384,Gastric Cancer Network 1 WP2361,0.7592051585181572,0.7156444099378882,0.19714803861449035,['NOTCH1'],0.9208543326646942,0,0,1
385,Kallmann's Syndrome WP5074,0.7592051585181572,0.7156444099378882,0.19714803861449035,['PRKCQ'],0.9208543326646942,0,0,1
386,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.7592051585181572,0.7156444099378882,0.19714803861449035,['UGCG'],0.9208543326646942,0,0,1
387,Methionine De Novo and Salvage Pathway WP3580,0.7592051585181572,0.7156444099378882,0.19714803861449035,['BHMT'],0.9208543326646942,0,0,1
388,NAD+ biosynthetic pathways WP3645,0.7592051585181572,0.7156444099378882,0.19714803861449035,['CD38'],0.9208543326646942,0,0,1
389,One-carbon metabolism WP241,0.7592051585181572,0.7156444099378882,0.19714803861449035,['BHMT'],0.9208543326646942,0,0,1
390,Purine metabolism and related disorders WP4224,0.7592051585181572,0.7156444099378882,0.19714803861449035,['GRM5'],0.9208543326646942,0,0,1
391,AGE/RAGE pathway WP2324,0.7767723781197694,0.7303345987463583,0.18448830475911104,"['LGALS3', 'IRS1', 'CYCS']",0.9208543326646942,0,0,3
392,miRNA regulation of DNA damage response WP1530,0.7767723781197694,0.7303345987463583,0.18448830475911104,"['SESN1', 'FAS', 'CYCS']",0.9208543326646942,0,0,3
393,Mitochondrial complex I assembly model OXPHOS system WP4324,0.7767723781197694,0.7303345987463583,0.18448830475911104,"['DMAC1', 'NDUFA5', 'NDUFS3']",0.9208543326646942,0,0,3
394,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.778565532185974,0.6734867860187553,0.16857516612181073,['MAP1LC3A'],0.9208543326646942,0,0,1
395,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.778565532185974,0.6734867860187553,0.16857516612181073,['MDH2'],0.9208543326646942,0,0,1
396,DNA damage response (only ATM dependent) WP710,0.7801373644538422,0.7624393624393624,0.18930246031590373,"['BCL6', 'IRS1', 'WNT7B', 'PIK3C2A', 'HRAS']",0.9208543326646942,0,0,5
397,"GPCRs, Class A Rhodopsin-like WP455",0.7837438135204725,0.6936096718480138,0.1690140054044681,"['EDNRA', 'NTSR2']",0.9208543326646942,0,0,2
398,Leptin signaling pathway WP2034,0.7870824906015391,0.7379492848289954,0.17668145567966326,"['SOCS3', 'IRS1', 'PLCG2', 'HRAS']",0.9208543326646942,0,0,4
399,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.7881951668080285,0.7150544605809128,0.17018978765402676,"['NOTCH1', 'PLCE1', 'SYNPO']",0.9208543326646942,0,0,3
400,7-oxo-C and 7beta-HC pathways WP5064,0.7963707621384719,0.6360133425350817,0.1448141450869888,['DBP'],0.9208543326646942,0,0,1
401,Glycerolipids and Glycerophospholipids WP4722,0.7963707621384719,0.6360133425350817,0.1448141450869888,['PNPLA3'],0.9208543326646942,0,0,1
402,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.7963707621384719,0.6360133425350817,0.1448141450869888,['RUNX2'],0.9208543326646942,0,0,1
403,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.7963707621384719,0.6360133425350817,0.1448141450869888,['VEGFA'],0.9208543326646942,0,0,1
404,Hippo-Yap signaling pathway WP4537,0.7963707621384719,0.6360133425350817,0.1448141450869888,['NDRG1'],0.9208543326646942,0,0,1
405,Immune response to tuberculosis WP4197,0.7963707621384719,0.6360133425350817,0.1448141450869888,['IFNAR2'],0.9208543326646942,0,0,1
406,Pre-implantation embryo WP3527,0.7963707621384719,0.6360133425350817,0.1448141450869888,['ATP1A1'],0.9208543326646942,0,0,1
407,Signal Transduction of S1P Receptor WP26,0.7963707621384719,0.6360133425350817,0.1448141450869888,['GNAI1'],0.9208543326646942,0,0,1
408,Vitamin D in inflammatory diseases WP4482,0.7963707621384719,0.6360133425350817,0.1448141450869888,['NFATC1'],0.9208543326646942,0,0,1
409,White fat cell differentiation WP4149,0.7963707621384719,0.6360133425350817,0.1448141450869888,['CEBPB'],0.9208543326646942,0,0,1
410,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.7963707621384719,0.6360133425350817,0.1448141450869888,['WIF1'],0.9208543326646942,0,0,1
411,Hedgehog Signaling Pathway WP4249,0.7968597474823887,0.6731484303565985,0.1528562509590751,"['BOC', 'GLI3']",0.9208543326646942,0,0,2
412,PDGF Pathway WP2526,0.7968597474823887,0.6731484303565985,0.1528562509590751,"['PAK1', 'HRAS']",0.9208543326646942,0,0,2
413,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.7991285480949804,0.7003980015242611,0.1570526672099509,"['PAK1', 'STMN1', 'HRAS']",0.9208543326646942,0,0,3
414,Mesodermal commitment pathway WP2857,0.8089709464752306,0.7454870379586481,0.15803749349870605,"['SMAD1', 'PRKAR1A', 'SESN1', 'HMGA2', 'RPL38', 'BMP7']",0.9208543326646942,0,0,6
415,3q29 copy number variation syndrome WP4906,0.8095852063443311,0.6863278008298755,0.14497525427634236,"['DYNLT3', 'PIGM', 'DYNLL2']",0.9208543326646942,0,0,3
416,DNA Mismatch Repair WP531,0.8127456479074135,0.6024844720496895,0.12491736791856325,['POLE3'],0.9208543326646942,0,0,1
417,Nanoparticle triggered autophagic cell death WP2509,0.8127456479074135,0.6024844720496895,0.12491736791856325,['MAP1LC3A'],0.9208543326646942,0,0,1
418,Oxidative Stress WP408,0.8127456479074135,0.6024844720496895,0.12491736791856325,['NQO1'],0.9208543326646942,0,0,1
419,Sphingolipid Metabolism (general overview) WP4725,0.8127456479074135,0.6024844720496895,0.12491736791856325,['UGCG'],0.9208543326646942,0,0,1
420,Unfolded protein response WP4925,0.8127456479074135,0.6024844720496895,0.12491736791856325,['TXNIP'],0.9208543326646942,0,0,1
421,Vitamin B12 metabolism WP1533,0.8127456479074135,0.6024844720496895,0.12491736791856325,['CUBN'],0.9208543326646942,0,0,1
422,Glycogen Synthesis and Degradation WP500,0.8209926060393201,0.635636154289004,0.12537362233377444,"['HKDC1', 'CALM3']",0.9269083969074174,0,0,2
423,Small cell lung cancer WP4658,0.8239811393018557,0.6929733471789546,0.13416493331252025,"['TRAF6', 'CYCS', 'LAMB1', 'RXRG']",0.9269083969074174,0,0,4
424,Fluoropyrimidine Activity WP1601,0.8278049834015929,0.5723084886128365,0.10815353021091989,['ABCC4'],0.9269083969074174,0,0,1
425,Sphingolipid Metabolism (integrated pathway) WP4726,0.8278049834015929,0.5723084886128365,0.10815353021091989,['UGCG'],0.9269083969074174,0,0,1
426,Wnt signaling in kidney disease WP4150,0.8278049834015929,0.5723084886128365,0.10815353021091989,['WNT7B'],0.9269083969074174,0,0,1
427,Gastrin signaling pathway WP4659,0.8305375896781129,0.7055773722440389,0.13101308074706408,"['PAK1', 'IRS1', 'PRKCQ', 'HRAS', 'VEGFA']",0.9273279818913052,0,0,5
428,ATM Signaling Network in Development and Disease  WP3878,0.8320678747368525,0.618400784203893,0.11368758014201838,"['HSPB1', 'CDK5R1']",0.9273279818913052,0,0,2
429,Ethanol effects on histone modifications WP3996,0.8416543584819167,0.5450064083604457,0.09395139276094698,['ACSS2'],0.9281350362665949,0,0,1
430,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.8416543584819167,0.5450064083604457,0.09395139276094698,['NDRG1'],0.9281350362665949,0,0,1
431,Oxidation by Cytochrome P450 WP43,0.8416543584819167,0.5450064083604457,0.09395139276094698,['CYP39A1'],0.9281350362665949,0,0,1
432,Type II interferon signaling (IFNG) WP619,0.8416543584819167,0.5450064083604457,0.09395139276094698,['SOCS3'],0.9281350362665949,0,0,1
433,Eukaryotic Transcription Initiation WP405,0.842520902942213,0.6020725388601036,0.10316922751000726,"['TAF13', 'POLR2G']",0.9281350362665949,0,0,2
434,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.8523800914737056,0.5865816394313804,0.09369042368045562,"['MAP1LC3A', 'PPP1R3C']",0.9368324968501327,0,0,2
435,Endometrial cancer WP4155,0.8551898847809549,0.6236514522821577,0.09755888634928735,"['EGF', 'HRAS', 'FGFR3']",0.9377599426218747,0,0,3
436,Wnt signaling WP428,0.8624980476284463,0.6438798941102482,0.09524425519104537,"['DAAM1', 'WIF1', 'WNT7B', 'NFATC1']",0.9432227737007401,0,0,4
437,16p11.2 distal deletion syndrome WP4950,0.8661039305679753,0.49752452966063554,0.07151933294282921,['PLN'],0.9432227737007401,0,0,1
438,Nanoparticle-mediated activation of receptor signaling WP2643,0.8661039305679753,0.49752452966063554,0.07151933294282921,['HRAS'],0.9432227737007401,0,0,1
439,BDNF-TrkB Signaling WP3676,0.8768756317035926,0.4767512077294686,0.0626403925403732,['HRAS'],0.9493636182827008,0,0,1
440,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.8768756317035926,0.4767512077294686,0.0626403925403732,['HRAS'],0.9493636182827008,0,0,1
441,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.8777135338840063,0.5912326513092002,0.07711743666036822,"['MDH1', 'FASN', 'DBI']",0.9493636182827008,0,0,3
442,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.8864255330835504,0.531823111218219,0.06411561468622198,"['WIF1', 'WNT7B']",0.9548415646432129,0,0,2
443,Melatonin metabolism and effects WP3298,0.8867815789034451,0.457639751552795,0.05498842467501353,['TRAF6'],0.9548415646432129,0,0,1
444,Nuclear receptors WP170,0.8958912888511267,0.43999840738971174,0.04837175413566566,['RXRG'],0.9624778035630348,0,0,1
445,Cardiac Hypertrophic Response WP2795,0.9005758861337614,0.5080944156591825,0.05320807746605145,"['EGF', 'MAP3K14']",0.9653363992939419,0,0,2
446,Kit receptor signaling pathway WP304,0.9070178161333269,0.4970038296913719,0.04850418726064541,"['HRAS', 'SH2B2']",0.9686351614576891,0,0,2
447,PDGFR-beta pathway WP3972,0.9119726283610781,0.4084960070984916,0.037640987988975014,['HRAS'],0.9686351614576891,0,0,1
448,Tumor suppressor activity of SMARCB1 WP4204,0.9119726283610781,0.4084960070984916,0.037640987988975014,['GLI3'],0.9686351614576891,0,0,1
449,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9136263670382564,0.5355128371369294,0.04837479166275818,"['EGF', 'MAP3K14', 'IGF1R']",0.9686351614576891,0,0,3
450,Cell cycle WP179,0.9138067560921596,0.5709761163032191,0.05146559256359502,"['YWHAB', 'YWHAZ', 'YWHAG', 'YWHAH']",0.9686351614576891,0,0,4
451,B Cell Receptor Signaling Pathway WP23,0.9277236770170789,0.5113953056295287,0.03836556742442526,"['BCL6', 'PLCG2', 'HRAS']",0.974940475988256,0,0,3
452,Acute viral myocarditis WP4298,0.9290729619974809,0.4570777202072539,0.03362629602472069,"['CYCS', 'ACTB']",0.974940475988256,0,0,2
453,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.9315630551058431,0.3688639551192146,0.026149281901358522,['IFITM3'],0.974940475988256,0,0,1
454,MAPK Cascade WP422,0.9315630551058431,0.3688639551192146,0.026149281901358522,['HRAS'],0.974940475988256,0,0,1
455,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.9315630551058431,0.3688639551192146,0.026149281901358522,['MAP3K14'],0.974940475988256,0,0,1
456,AMP-activated protein kinase (AMPK) signaling WP1403,0.933758735389616,0.4480747739510312,0.03070978475564687,"['CRTC2', 'FASN']",0.974940475988256,0,0,2
457,Integrated Cancer Pathway WP1971,0.9370722640687524,0.3573046066252588,0.023222968927708806,['BARD1'],0.974940475988256,0,0,1
458,Target Of Rapamycin (TOR) Signaling WP1471,0.9370722640687524,0.3573046066252588,0.023222968927708806,['FKBP1A'],0.974940475988256,0,0,1
459,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9381502693471896,0.43941809485850936,0.028054710199666766,"['WIF1', 'WNT7B']",0.974940475988256,0,0,2
460,IL-6 signaling pathway WP364,0.9510809155716088,0.32658976634131914,0.01638048051905626,['SOCS3'],0.9862295581036029,0,0,1
461,Genes related to primary cilium development (based on CRISPR) WP4536,0.9602894524894947,0.48531848611387285,0.01966536079895701,"['TMEM17', 'SCLT1', 'IFT27', 'KATNB1']",0.9936183705802364,0,0,4
462,DNA IR-damage and cellular response via ATR WP4016,0.9669737088438408,0.3742801325065829,0.012569813591651074,"['BARD1', 'BCL6']",0.9938738085966705,0,0,2
463,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9678526455549282,0.2856366459627329,0.009333299933373482,['MAP1LC3A'],0.9938738085966705,0,0,1
464,Energy Metabolism WP1541,0.9704423601796285,0.27864464980053527,0.008360250666951938,['CAMK4'],0.9938738085966705,0,0,1
465,Nucleotide Excision Repair WP4753,0.9704423601796285,0.27864464980053527,0.008360250666951938,['POLE3'],0.9938738085966705,0,0,1
466,DNA IR-double strand breaks and cellular response via ATM WP3959,0.9728236354626881,0.2719856058365375,0.007493875719237985,['TRAF6'],0.9938738085966705,0,0,1
467,Thermogenesis WP4321,0.9731716334681808,0.4122131680247963,0.011210061334493317,"['ACSL6', 'HRAS', 'ACTB']",0.9938738085966705,0,0,3
468,Joubert Syndrome WP4656,0.9784507136899466,0.34057690820508857,0.0074194211716019105,"['TMEM17', 'FLNA']",0.9938738085966705,0,0,2
469,Wnt signaling pathway and pluripotency WP399,0.9799426676906868,0.33553794574824747,0.006798405246591564,"['WNT7B', 'PRKCQ']",0.9938738085966705,0,0,2
470,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9805799998847671,0.24824466648663246,0.004868337515791283,['ACTB'],0.9938738085966705,0,0,1
471,Ciliary landscape WP4352,0.9813722512558319,0.5412068794114723,0.010176545877529317,"['NDUFA5', 'DYNLT3', 'CDH23', 'NEFL', 'IFT27', 'COPS7A', 'NEFM', 'COPS8', 'DYNLL2']",0.9938738085966705,0,0,9
472,Ciliopathies WP4803,0.9864750606303475,0.46422731423474695,0.00632149219811216,"['TMEM17', 'SCLT1', 'SPAG1', 'IFT27', 'PKD1L1', 'GLI3']",0.995206093804758,0,0,6
473,Endoderm differentiation WP2853,0.986860550041196,0.36361128277566873,0.004809317800279615,"['NOTCH1', 'SESN1', 'BMP7']",0.995206093804758,0,0,3
474,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.994940879893178,0.183914379215922,0.0009328065185557432,['CYCS'],0.9983757164962567,0,0,1
475,mRNA Processing WP411,0.997899098194929,0.28178046020369674,0.0005926158094903086,"['SF3B5', 'SNRPN', 'U2AF1']",0.9983757164962567,0,0,3
476,Circadian rhythm related genes WP3594,0.9980404579988078,0.2794452758315761,0.0005481219645945814,"['DBP', 'ID2', 'FAS']",0.9983757164962567,0,0,3
477,DNA Repair Pathways Full Network WP4946,0.9983757164962567,0.22300111754546378,0.0003625115270579642,"['APEX1', 'POLE3']",0.9983757164962567,0,0,2
